Day 1 :
Research Heart and Vascular Institute, USA
Keynote: The potential role of a unique, simple, quick, accurate, inexpensive, routine evaluation of Autonomic Nervous System(ANS) sympathetic(s) and parasympathetic(p) activity in cardiovascular diseases(CVD)
Time : 10:00-10:45
Gary L Murray received a Phi Beta Kappa Bachelor’s degree from Rhodes College, Memphis, TN, USA, receiving the Belk Bible Award for the most outstanding Bible student. After graduating from the Tulane University School of Medicine, New Orleans, LA, USA, his Postdoctoral training was at the University of Tennessee Center of Health Care Sciences, Memphis, TN, USA. He became Co-Director of the Cardiac Catheterization as well as Nuclear Cardiology laboratories at Baptist Hospital, Memphis, TN, USA. He then became Chief of Medicine, Nellis AFB, North Las Vegas, NV, USA. Since, he has been in private practice in Memphis, yet he has managed to publish several articles and co-created the Shad-Murray first pass RNA exercise test for coronary disease that was employed at many centers in the USA and Europe. He participated in clinical trials of the first elective coronary stent, as well as the first coronary atherectomy and laser devices. His ANS studies have been cited in the new textbook on clinical autonomic disorders by Colombo. He has spoken in several countries worldwide. He currently is Director of Research at the Heart and Vascular Institute, Germantown, TN, USA.
Evaluation of the important role the ANS plays in the development, progression, treatment, and prognosis of CVD has not been routine in clinical practice. However, new studies using a unique, easily applied technology have demonstrated the importance of ANS measures in the management of patients with risk factors for CVD, hypertension, orthostatic hypotension, congestive heart failure, and coronary disease. This new, unique technique and results of many studies will be discussed in detail. It is suggested that ANS measurement should be routinely used in CVD clinics, improving outcomes and lowering costs.
University of Edinburgh, Scotland
Time : 11:15-12:00
Matt graduated from Cambridge University in 1997. He joined the South East Scotland Emergency Medicine Training Programme in 2002 and has been a Consultant in Emergency Medicine in Edinburgh since 2007. Matt is also an Honorary Reader with the Acute Care group of the University of Edinburgh. After completing his Doctorate of Medicine thesis in 2009 on the risk stratification of syncope in the ED, Matt has continued research work in this area focusing on the use of biomarkers and ambulatory monitoring in syncope. He has published over 80 peer reviewed papers as well as numerous conference presentations and has personally been awarded over £950,000 in research contracts/grants in his career. Matt is Deputy Director and Founder member of EMERGE, a member of the RCEM Research and Publication Committee, a member of the European Society of Cardiology Syncope Task Force, a module co-lead on the Queen Mary University of London MSc Emergency & Resuscitation medicine, chair of the Royal Infirmary of Edinburgh Hospital Transfusion Committee and immediate past chair of the Scottish Transfusion and Support in Trauma Group.
Research Interests: Syncope/transient loss of consciousness, Emergency Department organ donation, Cardiac arrest
Matt will discuss how the current landscape of digital biomarker technology and mobile health is changing how we will deliver healthcare. He will talk about his own research in this area including the IPED multicentre study which has now finished recruiting and is investigating whether patient led mobile health technology can improve the detection of the underlying cause of symptomatic palpitations in patients who present acutely to the Emergency Department
St Luke’s Hospital, Greece
Time : 12:00-12:45
Kosmas Tsakiridis was born in northern Greece in 1967. He graduated from Medical School of Democritus University of Thrace in 1996, received a scholarship from the State Scholarship Foundation for two years, started his specialty training in Cardiac and Thoracic surgery (1998) and in 2006 he received the title from University of Cardiac and Thoracic Dept in University Hospital of Alexandroupolis, Thrace, Greece. He also completed his Doctorate study (Grade A) with the title “Effect of Lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass” on the April of 2006. Since then he has been working on the private sector. From 2010 to 2016 he was the Head of the Cardio-Thoracic Department of St. Lukes Hospital, Thessalonkiki, Greece where he conducted modern techniques in a variety of cardiac and thoracic cases (off pump, valve repair etc) and also thoracoscopic techniques (VATS) for lung diseases. Since 2017, he also operates in the private Hospital “Kyanous Stavros”, in Thessaloniki, Greece. Since 2018 he has been admitted to the European Board of Thoracic Surgery (FEBTS). He is also the Member of Hellenic Society of Thoracic and Cardiovascular Surgeons (HSTCS) and from 2014 General Secretary of the Committee, Euro Asian Bridge Society (EAB) and from 2015 Treasurer of the Committee, European Society of Thoracic Surgeons (ESTS), European Association of Cardiac and Thoracic Surgeons (EACTS), Gold Member in European Respiratory Society (ERS), Member in International Association for the Study of Lung Cancer (IASLC) and in Cardiothoracic Surgery Network - CTS Net (http://www.ctsnet.org/home/ktsakiridis). Member in World Society of Cardiac and Thoracic Surgeons (WSCTS) During his training he was Clinical Fellow at the Papworth Hospital, Cambridge, UK and participated in many medical workshops in Europe.
His activities involve: paper submission to international PubMed journals (http://www.ncbi.nlm.nih.gov/pubmed/?term=tsakiridis+k.) which are now 101 papers, participation in many European conventions, conferences and medical symposia organization as well as guest speaking in various meetings and congresses. Editor in scientific PubMed Journals (Journal of Thoracic Disease – JTD, Clinics in Oncology) and Reviewer in PubMed Journals (Onco Targets and Therapy, Therapeutics and Clinical Risk Management, Archives of Organ Transplantation) Within the context of the 5th and 7th meeting of the Thoracic Surgery Working Teams (Hellenic Society of Thoracic and Cardiovascular Surgeons) He has been awarded twice the 1st place in the cardiothoracic surgery knowledge contest.
Introduction: The use of skeletonized bilateral mammary arteries (BIMA) in myocardial revascularization in off pump cardiac surgery has been established the last decades. Nevertheless, there is still a lot discussion and serious controversies about the broad aspect of this operation. Up to date there is no study that has examined the feasibility and the effect of the systematic use of skeletonized BIMA.
Methods: A short review of the literature helped us compare our result over the last ten years. This is a single center, retrospective observational study with 500 patients undergoing coronary artery bypass grafting. The vast majority of the operations were off the pump. BIMA was harvested skeletonized either with electrocautery or ultracision harmonic scalpel.
Results: There is an interesting rise in the percentages of BIMA through the years, reaching 80% of the patients in the last three years. The operations are almost exclusively off the pump. The graft flow was also measured with no significant differences between the arterial grafts. There were no major adverse cardiac events or complications, neither serious wound infections.
Conclusions: The systematic use of BIMA is safe and can be the gold standard for patients. The real discussion over this topic should include the coronary artery site selected for revascularization with the right mammary artery, regarding the length and the quality of the arterial graft. Furthermore, the surgical experience is an independent factor as well.